@article { author = {Zakavi, S.Rasoul}, title = {AOJNMB in its second year of publication}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {1-2}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.001}, abstract = {No abstract.}, keywords = {No keywords}, url = {https://aojnmb.mums.ac.ir/article_2566.html}, eprint = {https://aojnmb.mums.ac.ir/article_2566_cb392849dd198e3be29b73d9f1a3b9ef.pdf} } @article { author = {Wong, Peter K. and Lee, Sze Ting and Murone, Carmel and Eng, John and Lawrentschuk, Nathan and Berlangieri, Salvatore U. and Pathmaraj, Kunthi and O&#039;Keefe, Graeme J. and Sachinidis, John and Byrne, Amanda J. and Bolton, Damien M. and Davis, Ian D. and Scott, Andrew M.}, title = {In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {3-11}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.002}, abstract = {Objective(s): The ability to measure cellular proliferation non-invasively in renal cell carcinoma may allow prediction of tumour aggressiveness and response to therapy. The aim of this study was to evaluate the uptake of 18Ffluorothymidine (FLT) PET in renal cell carcinoma (RCC), and to compare this to 18F-fluorodeoxyglucose (FDG), and to an immunohistochemical measure of cellular proliferation (Ki-67). Methods: Twenty seven patients (16 male, 11 females; age 42-77) with newly diagnosed renal cell carcinoma suitable for resection were prospectively enrolled. All patients had preoperative FLT and FDG PET scans. Visual identification of tumour using FLT PET compared to normal kidney was facilitated by the use of a pre-operative contrast enhanced CT scan. After surgery tumour was taken for histologic analysis and immunohistochemical staining by Ki-67. Results: The SUVmax (maximum standardized uptake value) mean±SD for FLT in tumour was 2.59±1.27, compared to normal kidney (2.47±0.34). The mean SUVmax for FDG in tumour was similar to FLT (2.60±1.08). There was a significant correlation between FLT uptake and the immunohistochemical marker Ki-67 (r=0.72, P<0.0001) in RCC. Ki-67 proliferative index was mean ± SD of 13.3%±9.2 (range 2.2% - 36.3%). Conclusion: There is detectable uptake of FLT in primary renal cell carcinoma, which correlates with cellular proliferation as assessed by Ki-67 labelling index. This finding has relevance to the use of FLT PET in molecular imaging studies of renal cell carcinoma biology.}, keywords = {FDG PET,FLT PET,Renal cell carcinoma}, url = {https://aojnmb.mums.ac.ir/article_2283.html}, eprint = {https://aojnmb.mums.ac.ir/article_2283_96578354274e1094025c50346211de20.pdf} } @article { author = {Kim, Jin Suk and Park, Shin Young}, title = {18F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {12-18}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.003}, abstract = {Objective(s): Expression of HER2 in gastric carcinoma has direct prognostic and therapeutic implications in patient management. The aim of this study is to determine whether a relationship exists between standardized uptake value (SUV) and expression of HER2 in advanced gastric carcinoma. Methods: We analyzed the 18F-FDG PET/CT results of 109 patients that underwent gastrectomy for advanced gastric carcinoma. The 18F-FDG PET/CT imaging was requested at the initial staging before surgery. The examinations were evaluated semi-quantitatively, with calculation of maximum standardized uptake values (SUVmax). The clinicopathologic factors, including HER2 overexpression, were determined from tissue obtained from the primary tumor. Metabolic and clincopathologic parameters were correlated using a t-test, one way ANOVA and chi-square test. Results: Immunohistochemically, 26 patients (23.8%) showed HER2 overexpression. This overexpression was significantly associated with high SUV level (P=0.02). The SUV level was significantly correlated with tumor size (P=0.02) and differentiation (P<0.001), and Lauren histologic type (P=0.04). Multivariate analysis showed HER2 overexpression, large tumor size, and differentiation (P=0.022, P=0.002, P<0.001) were significantly correlated with the high level of SUV in advanced gastric carcinoma. No association was found between SUV and T stage and lymph node metastasis. A receiver-operating characteristic curve demonstrated a SUVmax of 3.5 to be the optimal cutoff for predicting HER2 overexpression (sensitivity; 76.9%, specificity; 60.2%). Conclusion: An association exists between high SUV and HER2 overexpression and 18F-FDG PET/CT could be a useful tool to predict the biological characteristics of gastric carcinoma.}, keywords = {Advanced gastric carcinoma,HER2,PET-CT}, url = {https://aojnmb.mums.ac.ir/article_2219.html}, eprint = {https://aojnmb.mums.ac.ir/article_2219_d98d6a12b1e76fa47b21413da6030941.pdf} } @article { author = {Minamimoto, Ryogo and Senda, Michio and Jinnouchi, Seishi and Terauchi, Takashi and Inoue, Tomio}, title = {Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {19-23}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.004}, abstract = {Objective(s): The aim of this study was to analyze detection rates and effectiveness of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program for prostate cancer in Japan, which is defined as a cancer-screening program for subjects without known cancer. It contains FDG-PET aimed at detection of cancer at an early stage with or without additional screening tests such as prostate-specific antigen (PSA) and magnetic resonance imaging (MRI). Methods: A total of 92,255 asymptomatic men underwent the FDG-PET cancer screening program. Of these, 504 cases with findings of possible prostate cancer in any screening method were analyzed. Results: Of the 504 cases, 165 were verified as having prostate cancer. Of these, only 61 cases were detected by FDG-PET, which result in 37.0% relative sensitivity and 32.8% positive predictive value (PPV). The sensitivity of PET/computed tomography (CT) scanner was higher than that of dedicated PET (44.0% vs. 20.4%). However, the sensitivity of FDGPET was lower than that of PSA and pelvic MRI. FDG-PET did not contribute to improving the sensitivity and PPV when performed as combined screening. Conclusion: PSA should be included in FDG-PET cancer screening programs to screen for prostate cancer.}, keywords = {Cancer screening,FDG-PET,PET/CT,Prostate cancer,PSA}, url = {https://aojnmb.mums.ac.ir/article_2565.html}, eprint = {https://aojnmb.mums.ac.ir/article_2565_7fdd919c82d74a1541946d846ccf87b1.pdf} } @article { author = {Akamatsu, Mana and Yamashita, Yasuo and Akamatsu, Go and Tsutsui, Yuji and Ohya, Nobuyoshi and Nakamura, Yasuhiko and Sasaki, Masayuki}, title = {Influences of reconstruction and attenuation correction in brain SPECT images obtained by the hybrid SPECT/CT device: evaluation with a 3‐dimensional brain phantom}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {24-29}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.005}, abstract = {Objective(s): The aim of this study was to evaluate the influences of reconstruction and attenuation correction on the differences in the radioactivity distributions in 123I brain SPECT obtained by the hybrid SPECT/CT device. Methods: We used the 3-dimensional (3D) brain phantom, which imitates the precise structure of gray mater, white matter and bone regions. It was filled with 123I solution (20.1 kBq/mL) in the gray matter region and with K2HPO4 in the bone region. The SPECT/CT data were acquired by the hybrid SPECT/CT device. SPECT images were reconstructed by using filtered back projection with uniform attenuation correction (FBP-uAC), 3D ordered-subsets expectation-maximization with uniform AC (3D-OSEM-uAC) and 3D OSEM with CT-based non-uniform AC (3D-OSEM-CTAC). We evaluated the differences in the radioactivity distributions among these reconstruction methods using a 3D digital phantom, which was developed from CT images of the 3D brain phantom, as a reference. The normalized mean square error (NMSE) and regional radioactivity were calculated to evaluate the similarity of SPECT images to the 3D digital phantom. Results: The NMSE values were 0.0811 in FBP-uAC, 0.0914 in 3D-OSEM-uAC and 0.0766 in 3D-OSEM-CTAC. The regional radioactivity of FBP-uAC was 11.5% lower in the middle cerebral artery territory, and that of 3D-OSEM-uAC was 5.8% higher in the anterior cerebral artery territory, compared with the digital phantom. On the other hand, that of 3D-OSEM-CTAC was 1.8% lower in all brain areas. Conclusion: By using the hybrid SPECT/CT device, the brain SPECT reconstructed by 3D-OSEM with CT attenuation correction can provide an accurate assessment of the distribution of brain radioactivity.    }, keywords = {brain perfusion,SPECT/CT,CTAC,Chang method,Digital Phantom}, url = {https://aojnmb.mums.ac.ir/article_2273.html}, eprint = {https://aojnmb.mums.ac.ir/article_2273_6db07acc825b4b56bcbfe435574bbdfd.pdf} } @article { author = {Shinto, Ajit S and Kamaleshwaran, K. and Vyshak, K and Sudhakar, Natarajan and Banerjee, Sharmila and Korde, Aruna and Samuel, Grace and Mallia, Madhav}, title = {Clinical utility of indigenously formulated single-vial lyophilized HYNIC-TOC kit in evaluating Gastro-entero Pancreatic neuro endocrine tumours}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {30-41}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.006}, abstract = { Objective(s): The objective of this study was to evaluate the performance and utility of 99mTc HYNIC-TOC planar scintigraphy and SPECT/CT in the diagnosis, staging and management of gastroenteropancreatic neuroendocrine tumors (GPNETs). Methods: 22 patients (median age, 46 years) with histologically proven gastroentero-pancreatic NETs underwent 99mTc HYNIC-TOC whole body scintigraphy and regional SPECT/CT as indicated. Scanning was performed after injection of 370-550 MBq (10-15 mCi) of 99mTc HYNIC-TOC intravenously. Images were evaluated by two experienced nuclear medicine physicians both qualitatively as well as semi quantitatively (tumor to background and tumor to normal liver ratios on SPECT -CT images). Results of SPECT/CT were compared with the results of conventional imaging. Histopathology results and follow-up somatostatin receptor scintigraphy with 99mTc HYNIC TOC or conventional imaging with biochemical markers were considered to be the reference standards. Results: 99mTc HYNIC TOC showed sensitivity and specificity of 87.5% and 85.7%, respectively, for primary tumor and 100% and 86% for metastases. It was better than conventional imaging modalities for the detection of both primary tumor (P<0.001) and metastases (P<0.0001). It changed the management strategy in 6 patients (31.8%) and supported management decisions in 8 patients (36.3%). Conclusion: 99mTc HYNIC TOC SPECT/CT appears to be a highly sensitive and specific modality for the detection and staging of GPNETs. It is better than conventional imaging for the evaluation of GPNETs and can have a significant impact on patient management and planning further therapeutic options.}, keywords = {HYNIC TOC,Neuroendocrine tumor,SPECT CT}, url = {https://aojnmb.mums.ac.ir/article_2198.html}, eprint = {https://aojnmb.mums.ac.ir/article_2198_b6f0b3e80737a38caccd2dce6bd2600e.pdf} } @article { author = {Das, Jayanta and Ray, Soumendranath and Sen, Saugata and Chandy, Mammen}, title = {Extranodal involvement in lymphoma – A Pictorial Essay and Retrospective Analysis of 281 PET/CT studies}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {42-56}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.007}, abstract = {Objective(s): The aim of this study is to evaluate the role of PET-CT in identification of different patterns of extranodal involvement in Hodgkin’s disease (HD) and Non-Hodgkin’s Lymphoma (NHL) and to enlist the common sites of extranodal involvement in each histological type and compare our results with the existing literature. Methods: In this retrospective study of 281 cases of lymphomas of various histologies, we illustrate the spectrum of PET/CT features of extranodal lymphoma (ENL) of commonly involved organs and compare our result with the literature. Result: Extranodal appearance in lymphoma is strikingly varied. Diffuse large B cell lymphoma (DLBCL) is the commonest histological subtype and gastrointestinal tract is the commonest anatomical subsite in NHL. Skeletal system is the commonest site for involvement in HD. Conclusion: A broad spectrum of extranodal organs is involved in various subtype of lymphoma which can be depicted in PET-CT in the most appropriate manner. Familiarity with the pattern of involvement is essential for comprehensive management.}, keywords = {Hodgkin's disease,Lymphoma,PET/CT}, url = {https://aojnmb.mums.ac.ir/article_2304.html}, eprint = {https://aojnmb.mums.ac.ir/article_2304_2e580096ed7fa1b2c38f6b6bab30ee9b.pdf} } @article { author = {Canh, Nguyen Xuan and Tan, Ngo Van and Tung, Tran Thanh and Son, Nguyen Truong and Maurea, Simone}, title = {18F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {57-64}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.008}, abstract = {Neurolymphomatosis is a rare manifestation of non-Hodgkin lymphoma characterized by infiltration of peripheral nerves, nerve roots, plexus and cranial nerves by malignant lymphocytes. This report presents positron emission tomography/computed tomography (PET/CT)imaging with 2-deoxy-2-18F-fluoro-D-glucose (18F-FDG) in 3 cases of non-Hodgkin lymphoma with nerve infiltration, including one newly diagnosed lymphoma, one recurrent lymphoma in previous nerve lesions and one newly recurrent lymphoma. PET/CT could reveal the affected neural structures including cranial nerves, spinal nerve roots, brachial plexus, cervicothoracic ganglion, intercostal nerves, branches of the vagus nerve, lumbosacral plexus and sciatic nerves.There was relative concordance between PET/CT and MRI in detection of affected cranial nerves. PET/CT seemed to be better than MRI in detection of affected peripheral nerves. 18F-FDG PET/CT was a whole-body imaging technique with the ability to reveal the affected cranial nerves, peripheral nerves, nerve roots and plexus in non-Hodgkin lymphoma. A thorough understanding of disease and use of advanced imaging modalities will increasingly detect neurolymphomatosis}, keywords = {18F-FDG,Nerve,Neurolymphomatosis,PET/CT,Plexus}, url = {https://aojnmb.mums.ac.ir/article_2307.html}, eprint = {https://aojnmb.mums.ac.ir/article_2307_f9f34e1d89d4eb16d8842e7275124c6a.pdf} } @article { author = {Shiiba, Masato and Izutsu, Koji and Ishihara, Makiko}, title = {Early detection of intravascular large B-cell lymphoma by 18FDG-PET/CT with diffuse FDG uptake in the lung without respiratory symptoms or chest CT abnormalities}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {65-68}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.009}, abstract = {Intravascular large B-cell lymphoma (IVLBCL) is a rare and aggressive subtype of systemic extranodal non-Hodgkin diffuse large B-cell lymphoma (DLBCL). We report a rare case of IVLBCL who showed diffuse 18F-fluorodeoxyglucose (FDG) uptake in the lung in FDG-positron emission tomography/computed tomography (PET/CT) without respiratory symptoms or chest CT abnormalities. Serum biochemical studies showed a raised level of lactate dehydrogenase (LDH) and serum soluble interleukin-2 receptor (sIL-2R), which suggested the presence of malignant lymphoma strongly. A non-contrast CT showed no abnormalities in the lung fields, no lymphadenopathy was found. PET/CTFDG- revealed diffuse FDG uptake in the both lungs and in spleen as well as multiple hot spots in the liver. Under the suspicion of IVLBCL especially by the diffuse FDG uptake in the lung, a random skin biopsy was performed from three regions, the left forearm, right abdomen and left thigh in which there had been no evidence of FDG uptake. The definite diagnosis of IVLBCL was made based on the pathological analysis of the specimen from the left thigh. She achieved complete remission (CR) after combined chemoimmunotherapy. FDG-PET/CT was useful for the early detection of IVLBCL even without respiratory symptoms or any abnormal findings by chest CT.}, keywords = {IVLBCL,Intravascular large B-cell lymphoma,FDG-PET,Diffuse lung uptake}, url = {https://aojnmb.mums.ac.ir/article_2308.html}, eprint = {https://aojnmb.mums.ac.ir/article_2308_224ca3978fd32c01e6f5e8b9b8e1300d.pdf} } @article { author = {Higashiyama, Shigeaki and Kawabe, Joji and Yoshida, Atsushi and Kotani, Kohei and Shiomi, Susumu}, title = {Usefulness of three-phase bone scintigraphy and SPECT/CT for the diagnosis of bone lesions of systemic sarcoidosis}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {69-72}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.010}, abstract = {We report a three-phase bone scintigraphy for the diagnosis of a peripheral bone lesion caused by systemic sarcoidosis. A 32-year-old man with suspected osteomyelitis of the right forefinger underwent three-phase bone scintigraphy with Tc-99m hydroxymethylene diphosphonate (HMDP) and single-photon emission computed tomography/computed tomography (SPECT/CT). The lesion was rich in blood flow according to flow study and blood pool study on bone scintigraphy, and was associated with an osteolytic change on SPECT/CT imaging performed 3 hours after injection of a radioisotope (RI). Whole-body bone scintigraphy indicated multiple high levels of abnormal RI accumulation. The findings of the three-phase bone scintigraphy and SPECT/CT suggested the presence of systemic sarcoidosis; however, a subsequent 18Ffluorodeoxyglucose positron emission tomography/CT (FDG-PET/CT) could not exclude the possibility of multiple metastases from testicular tumors. Therefore, testicular enucleation was performed, and the pathological examination confirmed the presence of sarcoidosis.}, keywords = {Sarcoidosis SPECT/CT Tc,99m HMDP Three,phase bone scintigraphy}, url = {https://aojnmb.mums.ac.ir/article_2220.html}, eprint = {https://aojnmb.mums.ac.ir/article_2220_3baf6a78e241e8391b9e32ccbebad894.pdf} } @article { author = {Yamamoto, Yuka and Nishiyama, Yoshihiro}, title = {SPECT/CT imaging in bone scintigraphy of a case of clavicular osteoma}, journal = {Asia Oceania Journal of Nuclear Medicine and Biology}, volume = {2}, number = {1}, pages = {73-74}, year = {2014}, publisher = {Mashhad University of Medical Sciences in collaboration with AOFNMB}, issn = {2322-5718}, eissn = {2322-5726}, doi = {10.7508/aojnmb.2014.01.011}, abstract = {Osteoma is a benign bone-forming tumor that usually arises in the craniofacial bones and rarely in the long bones. Clavicular involvement is extremely rare. We report a 51-year-old woman with osteoma of the left clavicle. Radiograph of the left shoulder showed a well-defined lobulated blastic mass in the proximal and mid-portion of the left clavicle. Bone scintigraphy was performed 4 hours after an intravenous injection of Tc-99m hydroxymethylene diphosphonate (HMDP). Whole-body image showed a focus of intensely increased uptake in the clavicle. Single photon emission computed tomography/ computed tomography (SPECT/CT) images were also acquired and clearly showed intense uptake at the tumor site. Integrated SPECT/CT imaging supplies both functional and anatomic information about bone: the SPECT imaging improves sensitivity compared with planar imaging, the CT imaging provides precise localization of the abnormal uptake, and information on the shape and structure of the abnormalities improves the specificity of the diagnosis.}, keywords = {Bone scintigraphy,Osteoma,SPECT/CT,Tc‐99m HMDP}, url = {https://aojnmb.mums.ac.ir/article_2269.html}, eprint = {https://aojnmb.mums.ac.ir/article_2269_91f80ae60919f81870aac1a375814188.pdf} }